$750.00
Reconstituted at 60mg / 2mL
Retatrutide (Reconstituted) 60mg is a premier, high-purity triple agonist peptide solution targeting the GLP-1, GIP, and glucagon receptors. Engineered for advanced metabolic tracking, it accelerates lipolytic pathways and optimizes glucose homeostasis by combining appetite-suppressing incretin mimetics with glucagon-driven energy expenditure.
Supplied pre-mixed as a high-concentration liquid solution at 60mg / 2mL for streamlined laboratory evaluation. Keep refrigerated. Restricted strictly to laboratory and in vitro research applications.
Eterna Peptides presents premium-grade Retatrutide (Reconstituted) – 60mg, a groundbreaking synthetic peptide solution engineered for advanced metabolic, endocrine, and obesity-related research. This product is supplied pre-reconstituted in a liquid solution for immediate laboratory evaluation and streamlined experimental consistency.
Mechanism of Action
Retatrutide represents the cutting edge of incretin mimetic research, functioning as a highly potent triple hormone receptor agonist:
* **Triple Agonist Affinity:** It selectively binds to and activates three distinct metabolic receptor pathways: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and GCGR (glucagon receptor).
* **Synergistic Metabolic Upregulation:** While the GIP and GLP-1 pathways optimize insulin secretion and suppress appetite centers, the addition of glucagon receptor agonism increases energy expenditure and targets hepatic fat metabolism directly.
* **Unprecedented Lipolytic Efficiency:** Research indicates that this triple-targeting mechanism achieves a profound acceleration of fat mass reduction and glucose homeostasis compared to single or dual-receptor agonists.
Research Applications
In preclinical and in vitro research settings, Retatrutide is extensively utilized to study:
* High-velocity adipose tissue regression and severe metabolic dysfunction reversal.
* The molecular dynamics of triple incretin/glucagon receptor co-agonism.
* Cellular mechanisms involved in resolving non-alcoholic fatty liver pathways.
* Enhanced insulin sensitivity and glycemic homeostatic controls in advanced laboratory models.
Our pre-reconstituted Retatrutide solution undergoes stringent quality control testing to ensure absolute concentration accuracy, maximum peptide stability, and uniform batch-to-batch reproducibility.
—
*Disclaimer: This product is sold strictly for laboratory research and development use only. It is not intended for human consumption, diagnostic, or therapeutic purposes.*
